FURLANUT, Mario
 Distribuzione geografica
Continente #
NA - Nord America 8.048
AS - Asia 2.865
EU - Europa 2.007
SA - Sud America 356
Continente sconosciuto - Info sul continente non disponibili 241
AF - Africa 44
OC - Oceania 2
Totale 13.563
Nazione #
US - Stati Uniti d'America 7.931
SG - Singapore 1.413
CN - Cina 625
UA - Ucraina 548
DE - Germania 309
HK - Hong Kong 290
BR - Brasile 289
IT - Italia 231
SE - Svezia 191
FI - Finlandia 170
RU - Federazione Russa 165
VN - Vietnam 141
FR - Francia 110
TR - Turchia 103
IE - Irlanda 101
IN - India 73
GB - Regno Unito 72
CA - Canada 68
KR - Corea 46
BD - Bangladesh 39
MX - Messico 21
BE - Belgio 20
ES - Italia 19
CO - Colombia 18
ZA - Sudafrica 17
AR - Argentina 16
IQ - Iraq 16
IR - Iran 15
JP - Giappone 14
SA - Arabia Saudita 14
NL - Olanda 13
CZ - Repubblica Ceca 11
EC - Ecuador 10
PH - Filippine 9
PK - Pakistan 8
PL - Polonia 8
CL - Cile 7
ID - Indonesia 7
CR - Costa Rica 6
KZ - Kazakistan 6
MA - Marocco 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
EU - Europa 5
IL - Israele 5
LT - Lituania 5
UZ - Uzbekistan 5
BB - Barbados 4
JM - Giamaica 4
MY - Malesia 4
AL - Albania 3
AT - Austria 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KE - Kenya 3
NI - Nicaragua 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
TH - Thailandia 3
TN - Tunisia 3
UY - Uruguay 3
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
JO - Giordania 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MD - Moldavia 2
NP - Nepal 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
TJ - Tagikistan 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MK - Macedonia 1
ML - Mali 1
NO - Norvegia 1
Totale 13.318
Città #
Fairfield 880
Singapore 701
Ann Arbor 674
Woodbridge 647
Ashburn 640
Chandler 490
Houston 439
Seattle 352
Wilmington 351
Jacksonville 349
Beijing 312
San Jose 306
Hong Kong 290
Cambridge 284
Dearborn 212
Council Bluffs 166
Boardman 133
Dublin 100
Princeton 99
Izmir 89
Lauterbourg 88
New York 87
Udine 87
Los Angeles 80
Des Moines 58
San Diego 52
Santa Clara 50
Munich 49
Buffalo 47
Dallas 41
Ho Chi Minh City 41
Hanoi 37
Seoul 33
The Dalles 33
Ottawa 31
Orem 30
Hefei 29
Redondo Beach 27
Helsinki 25
São Paulo 24
Ogden 23
Mumbai 21
Brussels 20
Nanjing 19
Brooklyn 18
San Mateo 15
Turku 15
Denver 14
Frankfurt am Main 14
Kunming 14
Milan 14
San Francisco 13
Atlanta 12
Jinan 12
Shanghai 12
Tokyo 12
Augusta 11
Chicago 11
Falls Church 11
Guangzhou 11
Leawood 11
Manchester 11
Montreal 11
Rome 11
Trieste 11
Boston 10
Dhaka 10
Johannesburg 10
Norwalk 10
Phoenix 10
London 9
Mexico City 9
Monmouth Junction 9
Poplar 9
Belo Horizonte 8
Brno 8
Düsseldorf 8
Miami 8
Nanchang 8
Naples 8
Warsaw 8
Brasília 7
Chennai 7
Da Nang 7
Rio de Janeiro 7
Toronto 7
Winnipeg 7
Amsterdam 6
Ankara 6
Hebei 6
Lahore 6
Memphis 6
Moscow 6
Baku 5
Bologna 5
Changsha 5
Grafing 5
Padova 5
Riyadh 5
Salvador 5
Totale 9.065
Nome #
C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses. 213
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. 209
Chlorpromazine disposition in relation to age in children 201
Pharmacokinetic drug interaction between everolimus and antifungal triazoles in a liver transplant patient 200
Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients 198
Educational and Organizational Interventions to Improve the Usefulness of Clinical Pharmacological Advice for Personalized Drug Dosing Based on Therapeutic Drug Monitoring. 197
Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients 191
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy 184
A simple method to monitor serum concentrations of fluoxetine and its major metabolite for pharmacokinetic studies 181
Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation. 175
Calculating percentage prediction error: a user's note 172
Validation of limited sampling strategy for estimation of mycophenolic acid exposure during the first year after heart transplantation 171
No effect of clodronate on cyclosporin A blood levels in heart transplant patients simultaneously treated with diltiazem and azathioprine. 170
Hyperlactacidemia Potentially Due to Linezolid Overexposure in a Liver Transplant Recipient 170
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis 169
Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients 168
Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): Comparative pharmacokinetics and the role of therapeutic drug monitoring 166
The effect of multifactorial, multidisciplinary educational interventions on appropriate use of teicoplanin 165
Linezolid disposition after standard dosages in critically ill patients undergoing continuous venovenous hemofiltration: a report of 2 cases. 165
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions 165
Determination of tamoxifen and its metabolites in the endometrial tissue of long term treated women 164
Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients 162
Side effects of imipramine therapy in enuretic children. 161
What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice? 161
Acute oxcarbazepine, benazepril and hydrochlorothiazide overdose with alcohol 160
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis 159
Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis 159
Chronopharmacokinetics of ciclosporin and tacrolimus 158
High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures 156
Pharmacology of ifosfamide 154
Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery 154
Effect of fluctuations of blood cyclosporine concentrations on renal function. 153
Blood concentrations and clinical effect of cyclosporin in psoriasis 153
A SIMPLE METHOD TO MONITOR PLASMA CONCENTRATIONS OF OXCARBAZEPINE,CARBAMAZEPINE, THEIR MAIN METABOLITES AND LAMOTRIGINE IN EPILEPTIC PATIENTS 153
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia 153
TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients 153
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective 150
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia 149
Antimicrobial agents in elective surgery: Prophylaxis or "early therapy"? 148
Pharmacokinetic-pharmacodynamic aspecte of antimicrobial prophylaxis with teisoplanin in patients undergoing major vascular surgery 148
Major role of levofloxacin in the treatment of a case of Listeria monocytogenes meningitis 147
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia 147
Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomy 147
Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin 147
Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy 146
Plasma levels of levodopa. Its main metabolites and carbidopa after conventional and slow release levodopa-carbidopa treatment in parkinsonian patients. 145
Fluoxetine disposition in patients suffering from chronic hepatitis C treated with interferon alpha 145
A simple and sensitive HPLC method ti monitor serum and synovial fluid concnetrations of ketorolac in reumathologic patients 144
Daunorubicin and daunorubicinol tissue concentrations in gastric cancer patients after local administration of a liposomal preparation 144
AM and PM C2 monitoring of cyclosporine in liver transplant recipients 144
Urinary Pharmacokinetics and Theoretical Pharmacodynamics of Intravenous Levofloxacin in Intensive Care Unit Patients Treated with 500 mg b.i.d. for Ventilator-Associated Pneumonia 144
Imipramine pharmacokinetics in depressed geriatric patients 142
Therapeutic drug monitoring of lamotrigine in patients suffering from resistant partial seizures 142
Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients 141
Teicoplanin therapeutic drug monitoring in critically ill patients: A retrospective study emphasizing the importance of a loading dose 140
Somatomedin C (insulin-like growth factor 1) levels decrease during acute changes of stress related hormones. Relevance for fibromyalgia. 137
Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: A pharmacokinetics/pharmacodynamics-based approach 137
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure 136
Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients 130
Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis 129
Effect of the number of samples on bayesian and non-linear least-squares individualization: A study of cyclosporin treatment of haematological patients with multidrug resistance 128
TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient 128
Is the use of vancomycin doses of at least 1 g every 8 hours the only way to achieve optimal trough levels in critically ill trauma patients with pneumonia and normal renal function? 127
Antimicrobial therapy in critically ill patients: A review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability 127
Tamoxifen and its main metabolites serum and tissue concentration in breast cancer women 123
Penetration of levofloxacin into paranasal sinuses mucosa of patients with chronic rhinosinusitis after a single 500 mg oral dose 122
Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients 121
Isoniazid and its hydrazine metabolite in patients with tuberculosis 121
MEGX disposition in critically-ill trauma patients: Subsequent assessments during the first week following trauma 120
Successful long-term treatment of cerebral nocardiosis with unexpectedly low doses of linezolid in an immunocompromised patient receiving complex polytherapy 118
Inter-patient and intra-patient variations in the baseline tapping test in patients with Parkinson's disease 117
CYCLOSPORINE-A (CSA) PLUS CHEMOTHERAPY (CHT) IN-VIVO, TO OVERCOME MULTIDRUG-RESISTANCE (MDR) 117
Pharmacokinetic profile of two different administration schemes of teicoplanin. Single 400 mg intravenous dose vs double-refracted 200 mg intramuscular doses in healthy volunteers 115
Oral gabapentin disposition in patients with epilepsy after a high-protein meal 114
Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association 113
Un caso di encefalite da Mycoplasma pneumoniae trattato con levofloxacina 111
Optimisation of vancomycin regimen in neutropenic haematological patients with normal renal function. Multiple daily doses may be preferable 109
Therapeutic drug monitoring-guided high teicoplanin dosage regimen required to treat a hypoalbuminemic renal transplant patient undergoing continuous venovenous hemofiltration 106
Nicotine and cotinine plasma concentrations: Useful markers to optimize nicotine replacement therapy in smokers 105
Cyclosporin nephrotoxicity in relation to its pharmacokinetics in man 105
Oral and intravenous disposition of cyclosporine in psoriatic patients. 104
CYCLOSPORINE-A PLUS CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA 103
Monitoraggio del Gabapentine e della Lamotrigina in pazienti con crisi parziali complesse 103
Preliminary observations on serum concentrations of tamoxifen and its main metabolites in patients with breast cancer 101
Farmacologia generale e clinica per le lauree sanitarie - III Edizione - Ed. Piccin 100
Is antimicrobial underexposure due to glomerular hyperfiltration a possible cause of increased mortality rate from bacterial infections in critically ill patients? 98
Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods 98
Pharmacokinetic aspects of levofloxacin 500 mg once-daily during sequential intravenous/oral therapy in patients with lower respiratory tract infections 98
Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages 95
Systemic vancomycin overexposure in a patient with spinal cord injury who had staphylococcal sepsis and Clostridium difficile colitis 95
Farmacologia - Principi e applicazioni 93
FARMACOLOGIA CLINICA DELL'ENURESI PRIMARIA 91
Farmacologia generale e clinica per le lauree sanitarie - II edizione 86
Personalization of antimicrobial dosing regimens: Indicators of performance 80
Farmacologia generale e clinica per le lauree triennali 78
P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases 76
Variability in the metabolism of levodopa and clinical implications 75
Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients 70
Totale 13.563
Categoria #
all - tutte 49.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.399


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022833 0 0 47 89 48 50 43 42 15 154 209 136
2022/20231.021 112 90 18 127 132 276 0 74 130 13 20 29
2023/2024319 55 23 7 5 60 72 6 19 36 6 2 28
2024/20251.656 40 110 104 45 73 87 89 107 139 117 312 433
2025/20263.246 295 356 236 276 522 269 467 91 230 274 153 77
2026/2027386 54 207 125 0 0 0 0 0 0 0 0 0
Totale 13.563